BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6536522)

  • 21. NTP Toxicology and Carcinogenesis Studies of Isobutyraldehyde (CAS No. 78-84-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 472():1-242. PubMed ID: 12579201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity.
    Gart JJ; Chu KC; Tarone RE
    J Natl Cancer Inst; 1979 Apr; 62(4):957-74. PubMed ID: 285297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategy of long-term animal testing for quantitative evaluation of chemical carcinogenicity.
    Hayashi Y; Kurokawa Y; Maekawa A; Takahashi M
    Dev Toxicol Environ Sci; 1986; 12():383-91. PubMed ID: 3549239
    [No Abstract]   [Full Text] [Related]  

  • 24. Statistical design of toxicity assays: role of genetic structure of test animal population.
    Haseman JK; Hoel DG
    J Environ Pathol Toxicol; 1979; 2(6):1313-27. PubMed ID: 528844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies.
    McConnell EE; Solleveld HA; Swenberg JA; Boorman GA
    J Natl Cancer Inst; 1986 Feb; 76(2):283-9. PubMed ID: 3456066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An alternative approach to the analysis of animal carcinogenicity studies.
    Stallard N; Whitehead A
    Regul Toxicol Pharmacol; 1996 Jun; 23(3):244-8. PubMed ID: 8812967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of non-mammalian species in bioassays for carcinogenicity.
    Bunton TE
    IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of styrene and styrene oxide long-term animal studies.
    McConnell EE; Swenberg JA
    Crit Rev Toxicol; 1994; 24 Suppl():S49-55. PubMed ID: 7818772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current problems in the choice of animals for toxicity testing.
    Stevenson DE
    J Toxicol Environ Health; 1979 Jan; 5(1):9-15. PubMed ID: 423310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk assessment of carcinogens: present status and future directions.
    Munro IC
    Biomed Environ Sci; 1988 Jun; 1(1):51-8. PubMed ID: 3077260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of carcinogenicity studies, dose selection, route, blood levels, transformation.
    Neal RA
    Toxicol Pathol; 1983; 11(1):48-54. PubMed ID: 6681396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strengths and weaknesses of long-term bioassays.
    Schach von Wittenau M
    Regul Toxicol Pharmacol; 1987 Mar; 7(1):113-9. PubMed ID: 3575793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of investigative toxicology in pharmaceutical industry.
    Harpur ES; Bonner FW
    Arch Toxicol Suppl; 1994; 16():176-82. PubMed ID: 8192579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mouse versus the rat in carcinogen bioassays.
    Clayson DB
    Fundam Appl Toxicol; 1984 Jun; 4(3 Pt 1):499-501. PubMed ID: 6745541
    [No Abstract]   [Full Text] [Related]  

  • 39. An IARC appraisal of carcinogenicity testing.
    Food Cosmet Toxicol; 1981 Dec; 19(6):783-5. PubMed ID: 7327483
    [No Abstract]   [Full Text] [Related]  

  • 40. Toxicity was defined as any deleterious change that was discerned by histopathology.
    Goodman JI
    Mol Carcinog; 1992; 5(4):247-9. PubMed ID: 1497799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.